Belite Bio, Inc (BLTE) stock

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30

$169.96+14.02 (+8.99%)

Close on Nov 12, 2026Market cap $6.69BP/E –Yield –

Belite Bio statistics

64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Dec 31, 2025
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $6.69B; $280.48M
Enterprise Value: $6.33B; $148.62M
PB Ratio: 8.68; 2.05
P/TBV Ratio: 8.68; 2.29

Share statisticsIndustry

Shares Outstanding: 39M; 58M
Shares Change (YoY): 9.82%; 10.9%
Float: 21M; 49M
Shares Held by Insiders: 47.3%; 12.1%
Shares Held by Institutions: 24.1%; 56.4%

Short sellingIndustry

Short Interest: 1M; –
Short Interest Change: 8.92%; -0.76%
Days to Cover: 9.96; 5.13

Stock price statisticsIndustry

52-Week High: $200.00; –
52-Week Low: $105.88; –
20-Day Moving Average: $151.78; –
50-Day Moving Average: $161.02; –
200-Day Moving Average: $160.13; –
Average True Range (14): $7.88; –
Price Change (1 Week): 18.7%; 1.51%
Price Change (1 Month): 11.3%; -2.37%
Price Change (3 Months): 4.40%; -21.1%
Price Change (6 Months): 13.3%; -22.8%
Price Change (YTD): 6.25%; -22.6%
Price Change (1 Year): 60.7%; -21.0%
Price Change (3 Years): 332.5%; -24.8%
Average Volume (10 Days): 216,861; –
Average Volume (20 Days): 173,817; –
Average Volume (90 Days): 178,970; –
Relative Volume: 2.81; 0.80
Relative Strength Index (14): 63.0; 44.7
Volatility (1 Year): 53.7%; 80.2%
Beta (5 Years): 0.18; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -16.9%; -51.3%
Return on Assets (ROA): -16.6%; -40.7%
Return on Invested Capital (ROIC): -25.2%; -32.9%
Return on Capital Employed (ROCE): -10.9%; -38.1%

Financial positionIndustry

Current Ratio: 50.02; 3.31
Quick Ratio: 35.71; 2.41
Interest Coverage: -42104.00; -6.35

EfficiencyIndustry

Profits Per Employee: -$155.22K; -$683.67K
Employee Count: 500; 75
WACC: 7.38%; 10.0%

Income statement (TTM)Industry

Operating Income: -$84.21M; -$20.99M
Pretax Income: -$77.61M; -$13.23M
Net Income: -$77.61M; -$21.61M
EBITDA: -$84.21M; -$16.85M
EPS (Diluted): -$2.31; -$0.75

Balance sheetIndustry

Cash & Short-Term Investments: $352.93M; $67.18M
Net Cash (Debt): $352.93M; $16.98M
Net Cash Per Share: $8.97; $0.72
Equity (Book Value): $770.49M; $52.68M
Book Value Per Share: $19.59; $1.50
Tangible Book Value: $770.47M; $26.74M
Working Capital: $484.39M; $78.52M

Cash flow (TTM)Industry

Operating Cash Flow: -$36.99M; -$12.27M
Capital Expenditures: -$71.00K; -$944.00K
Free Cash Flow: -$37.06M; -$18.20M
FCF Per Share: -$0.94; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -1.16%; -21.0%
FCF Yield: -0.55%; -9.44%

Taxes and interestIndustry

Interest Expense: $2.00K; $2.97M
Income Tax: $0; $74.00K

Scores and fair valueIndustry

Altman Z-Score: 398.44; 0.26
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	BLTE	S&P 500	Difference	BLTE per year	S&P 500 per year
1 month	+7.2%	-2.7%	+9.9 pts
3 months	-5.0%	-1.7%	−3.3 pts
Year to date	+6.3%	+11.9%	−5.6 pts
1 year	+53.4%	+12.0%	+41.4 pts
3 years	+332.0%	+78.2%	+253.9 pts	+62.9%	+21.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M BLTE shares were sold short on Oct 30, 2026, up 8.9% from the previous report. At recent volumes it would take 10.0 days to buy them back. Over the last 20 sessions, 72.7% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	1,380,466	+8.9%	138,665	10.0
Oct 15, 2026	1,267,440	+19.8%	178,362	7.1
Sep 30, 2026	1,057,536	+0.7%	145,206	7.3
Sep 15, 2026	1,050,466	+0.1%	274,217	3.8
Aug 31, 2026	1,049,817	-6.0%	141,528	7.4
Aug 14, 2026	1,116,380	-1.6%	191,273	5.8
Jul 31, 2026	1,134,633	-13.7%	168,803	6.7
Jul 15, 2026	1,315,070	+0.1%	186,330	7.1
Jun 30, 2026	1,314,142	-0.8%	247,077	5.3
Jun 15, 2026	1,324,951	+10.3%	238,100	5.6
May 29, 2026	1,201,317	+0.9%	242,599	5.0
May 15, 2026	1,191,024	-3.4%	122,831	9.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?